|Dr. Charles J. Fisher Jr., M.D.||CEO, Director & Member of Extracorporeal Therapy Advisory Board||460k||N/A||1947|
|Mr. Guy F. Cipriani BS (Eng.), MBA||Sr. VP, Chief Bus. Officer & Director||347.5k||N/A||1970|
|Dr. Steven P. LaRosa M.D.||Chief Medical Officer||430k||N/A||1967|
|Mr. James B. Frakes M.B.A.||CFO, Sr. VP of Fin. & Sec.||N/A||N/A||1957|
|Dr. Lee D. Arnold Ph.D.||Chief Scientific Officer||N/A||N/A||1960|
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.
Aethlon Medical, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.